Heart rhythm, also known as cardiac rhythm, is a critical aspect of cardiovascular health that regulates the beating of the heart. The heart, a powerful muscular organ, relies on a coordinated electrical system to contract and pump blood efficiently throughout the body. This intricate orchestration is essential for maintaining proper circulation and delivering oxygen and nutrients to various organs and tissues. The heart rhythm is typically measured in beats per minute (BPM), with a normal range between 60 and 100 BPM at rest. Disturbances in heart rhythm, known as arrhythmias, can manifest as irregular beats, palpitations, or an abnormal pace. Some arrhythmias are harmless, while others may pose serious health risks. Conditions such as atrial fibrillation (AFib) and ventricular tachycardia (VT) are examples of irregular heart rhythms that may require medical attention. Monitoring and understanding heart rhythm play a crucial role in diagnosing and managing cardiovascular disorders, ensuring the heart functions optimally for overall well-being. Regular check-ups and consultations with healthcare professionals are key to maintaining a healthy heart rhythm and preventing potential complications.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India